Free Trial

Smart for Life (SMFL) Competitors

Smart for Life logo
$0.02 +0.02 (+305.88%)
As of 07/18/2025 03:34 PM Eastern

SMFL vs. HEPA, BPTSY, VRPX, VIRX, NCNA, BON, CAPS, MYMD, VINC, and UPC

Should you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Hepion Pharmaceuticals (HEPA), Biophytis (BPTSY), Virpax Pharmaceuticals (VRPX), Viracta Therapeutics (VIRX), NuCana (NCNA), Bon Natural Life (BON), Capstone Therapeutics (CAPS), MyMD Pharmaceuticals (MYMD), Vincerx Pharma (VINC), and Universe Pharmaceuticals (UPC). These companies are all part of the "pharmaceutical products" industry.

Smart for Life vs. Its Competitors

Smart for Life (NASDAQ:SMFL) and Hepion Pharmaceuticals (NASDAQ:HEPA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

28.4% of Smart for Life shares are owned by institutional investors. Comparatively, 17.2% of Hepion Pharmaceuticals shares are owned by institutional investors. 31.7% of Smart for Life shares are owned by insiders. Comparatively, 0.1% of Hepion Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Smart for Life has higher revenue and earnings than Hepion Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smart for Life$11.11M0.01-$22.68MN/AN/A
Hepion PharmaceuticalsN/AN/A-$48.93M-$219.000.00

Smart for Life's return on equity of 0.00% beat Hepion Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Smart for LifeN/A N/A N/A
Hepion Pharmaceuticals N/A -812.56%-207.31%

Smart for Life has a beta of 17.24, indicating that its stock price is 1,624% more volatile than the S&P 500. Comparatively, Hepion Pharmaceuticals has a beta of 1.69, indicating that its stock price is 69% more volatile than the S&P 500.

In the previous week, Smart for Life's average media sentiment score of 0.00 equaled Hepion Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Smart for Life Neutral
Hepion Pharmaceuticals Neutral

Summary

Smart for Life beats Hepion Pharmaceuticals on 7 of the 7 factors compared between the two stocks.

Get Smart for Life News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMFL vs. The Competition

MetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$147K$3.44B$5.54B$9.40B
Dividend YieldN/AN/A3.75%4.03%
P/E RatioN/A7.6228.0119.79
Price / Sales0.0126.38432.5697.34
Price / CashN/A5.6236.1658.27
Price / Book0.001.108.125.65
Net Income-$22.68M$17.44M$3.25B$257.91M
7 Day PerformanceN/A-12.86%1.64%3.35%
1 Month PerformanceN/A-6.41%7.27%11.09%
1 Year PerformanceN/A-37.62%32.88%18.99%

Smart for Life Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMFL
Smart for Life
N/A$0.02
+305.9%
N/A-99.0%$147K$11.11M0.00110
HEPA
Hepion Pharmaceuticals
0.1377 of 5 stars
$0.05
-6.4%
N/A-99.9%$528KN/A-0.0120Gap Up
BPTSY
Biophytis
N/A$1.33
-8.3%
N/A-71.3%$467KN/A0.0030Gap Down
VRPX
Virpax Pharmaceuticals
N/A$0.36
-2.5%
$75.00
+20,675.6%
-98.8%$448KN/A0.007
VIRX
Viracta Therapeutics
2.0262 of 5 stars
$0.01
-5.0%
$1.75
+18,129.2%
N/A$382KN/A-0.0120High Trading Volume
NCNA
NuCana
3.0679 of 5 stars
$0.05
+9.4%
$25.00
+49,700.8%
-98.4%$280KN/A-0.0130Stock Split
Gap Up
High Trading Volume
BON
Bon Natural Life
0.6073 of 5 stars
$1.48
-3.3%
N/AN/A$260K$23.84M0.00100Gap Down
CAPS
Capstone Therapeutics
N/A$1.51
-5.0%
N/AN/A$251K$43.42M0.0038
MYMD
MyMD Pharmaceuticals
N/A$0.10
-6.3%
N/A-94.7%$242KN/A0.006Gap Down
High Trading Volume
VINC
Vincerx Pharma
3.1812 of 5 stars
$0.04
-7.5%
$40.00
+92,923.3%
-99.7%$225KN/A0.0060Gap Up
UPC
Universe Pharmaceuticals
N/A$3.72
-2.9%
N/A-99.9%$160K$19.29M0.00220

Related Companies and Tools


This page (NASDAQ:SMFL) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners